Supplementary Table 3 from Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

Authors :: Bob T. Li
Gilles Gallant
Takahiro Jikoh
Jasmeet Singh
Masahiro Sugihara
Kaku Saito
Trisha M. Wise-Draper
Kenji Tamura
Charles Redfern
Haeseong Park
Shunji Takahashi
Toshihiko Doi
Pasi A. Jänne
Ian Krop
Hiroji Iwata
Junji Tsurutani
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Inclusion and exclusion criteria for cohort 2d (advanced HER2-expressing non-breast/non-gastric or HER2-mutant solid tumors)

Full Text Access

Tools